Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine Stedman

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Therapeutic Advances in Gastroenterology|May 3, 2014
Sofosbuvir, a NS5B polymerase inhibitor in the treatment of hepatitis C: a review of its clinical potentialCatherine Stedman
Seminars in Liver Disease|May 23, 2002
Herbal hepatotoxicityCatherine Stedman
British Journal of Clinical Pharmacology|August 23, 2021
A case of acute necrotising pancreatitis following the second dose of Pfizer-BioNTech COVID-19 mRNA vaccineTalia Walter, Saxon Connor, Catherine Stedman, et al.
The Journal of Biological Chemistry|December 19, 2003
Feed-forward regulation of bile acid detoxification by CYP3A4: studies in humanized transgenic miceCatherine Stedman, Graham Robertson, Sally Coulter, et al.
The New Zealand Medical Journal|December 23, 2014
Impact of improved treatment on disease burden of chronic hepatitis C in New ZealandEdward Gane, Catherine Stedman, Cheryl Brunton, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 18, 2006
Benefit of farnesoid X receptor inhibition in obstructive cholestasisCatherine Stedman, Christopher Liddle, Sally Coulter, et al.
ACS Infectious Diseases|October 30, 2016
A Diacylglycerol Transferase 1 Inhibitor Is a Potent Hepatitis C Antiviral in Vitro but Not in Patients in a Randomized Clinical TrialEdward Gane, Catherine Stedman, Kiran Dole, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 21, 2017
Transient elastography to assess liver stiffness in patients with inflammatory bowel diseaseBerrie Meijer, Charlotte K van Everdingen, Dewkoemar Ramsoekh, et al.
Journal of Hepatology|March 1, 2011
Antiviral activity, safety, and pharmacokinetics of danoprevir/ritonavir plus PEG-IFN α-2a/RBV in hepatitis C patientsEdward J Gane, Regine Rouzier, Catherine Stedman, et al.
JHEP Reports : Innovation in Hepatology|September 29, 2023
Glecaprevir-pibrentasvir for 4 weeks among people with recent HCV infection: The TARGET3D studyMarianne Martinello, Sanjay Bhagani, David Shaw, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Therapeutic Advances in Gastroenterology|May 3, 2014
Sofosbuvir, a NS5B polymerase inhibitor in the treatment of hepatitis C: a review of its clinical potentialCatherine Stedman
Seminars in Liver Disease|May 23, 2002
Herbal hepatotoxicityCatherine Stedman
British Journal of Clinical Pharmacology|August 23, 2021
A case of acute necrotising pancreatitis following the second dose of Pfizer-BioNTech COVID-19 mRNA vaccineTalia Walter, Saxon Connor, Catherine Stedman, et al.
The Journal of Biological Chemistry|December 19, 2003
Feed-forward regulation of bile acid detoxification by CYP3A4: studies in humanized transgenic miceCatherine Stedman, Graham Robertson, Sally Coulter, et al.
The New Zealand Medical Journal|December 23, 2014
Impact of improved treatment on disease burden of chronic hepatitis C in New ZealandEdward Gane, Catherine Stedman, Cheryl Brunton, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 18, 2006
Benefit of farnesoid X receptor inhibition in obstructive cholestasisCatherine Stedman, Christopher Liddle, Sally Coulter, et al.
ACS Infectious Diseases|October 30, 2016
A Diacylglycerol Transferase 1 Inhibitor Is a Potent Hepatitis C Antiviral in Vitro but Not in Patients in a Randomized Clinical TrialEdward Gane, Catherine Stedman, Kiran Dole, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 21, 2017
Transient elastography to assess liver stiffness in patients with inflammatory bowel diseaseBerrie Meijer, Charlotte K van Everdingen, Dewkoemar Ramsoekh, et al.
Journal of Hepatology|March 1, 2011
Antiviral activity, safety, and pharmacokinetics of danoprevir/ritonavir plus PEG-IFN α-2a/RBV in hepatitis C patientsEdward J Gane, Regine Rouzier, Catherine Stedman, et al.
JHEP Reports : Innovation in Hepatology|September 29, 2023
Glecaprevir-pibrentasvir for 4 weeks among people with recent HCV infection: The TARGET3D studyMarianne Martinello, Sanjay Bhagani, David Shaw, et al.
Pageof 2